The landscape of dementia prognosis has developed significantly with the arrival of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology years just before signs or symptoms arise. Whilst these technological improvements characterize outstanding progress in knowledge neurodeg